The pharmaceutical filtration market is expected to cross $27.7 billion by 2023, growing at a CAGR of over 10.6% between 2017-2023. Increasing prevalence of chronic diseases, increasing geriatric population and surging healthcare expenditure leading to increased spending on R&D are some of the key drivers for the global market growth. In addition, growing cases of cancer and increasing production of biopharmaceuticals and generic drugs also support the market growth.
Request for Sample Copy of this Research Report: https://www.psmarketresearch.com/market-analysis/pharmaceutical-filtration-market/report-sample
As per the findings of the research, the membrane filter is the largest product category in the global pharmaceutical filtration market. Membrane filter is the microporous film with specific pore size, used for retaining unwanted particles or microorganisms larger than their pore size. Microfiltration has been the largest contributor to the growth of the global market, in terms of revenue, among the various techniques for product filtration. Final product processing has been the largest application area for pharmaceutical filtration, followed by raw material filtration, cell separation, water purification and air purification. Manufacturing-scale of operation has been the largest segment of the global market, based on scale of operation.
The increasing demand and penetration of pharmaceutical filtration products in emerging economies offers enormous growth opportunities for the pharmaceutical filtration market. With high economic growth and increasing government initiatives in Asia-Pacific, the major manufacturers of the pharmaceutical filtration products are penetrating into the untapped market in the region. Countries such as China and India have a huge growth potential for the market during the forecast years. The healthcare industry is witnessing significant growth in these countries. The large population base and improving healthcare infrastructure are attracting pharmaceutical filtration product manufacturers to develop their manufacturing sites in these countries. Moreover, manufacturing of such products in the developing regions tends to decrease the overall cost of manufacturing, thus reducing the cost of the product without altering its quality. Pharmaceutical filtration products such as membrane filter, prefilter and depth media filter, cartridge and capsule filter, filter holder, filtration accessories and other products play a vital role in filtration process and preventing contamination. Therefore, ease of healthcare access in these countries creates ample growth opportunities for the pharmaceutical filtration market.
Some of the key players in the pharmaceutical filtration market include Merck KGaA, Pall Corporation, GE Healthcare, 3M Company, Parker Hannifin Corporation, Sartorius Stedim Biotech S.A., Eaton Corporation PLC, Graver Technologies, LLC, Amazon Filters Ltd. and Meissner Filtration Products, Inc.